How were Adamis Pharmaceuticals' earnings last quarter?

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) released its earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($4.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.80) by $1.40. Adamis Pharmaceuticals had a negative net margin of 502.73% and a negative trailing twelve-month return on equity of 420.53%. During the same quarter in the previous year, the business earned ($11.20) EPS.

When did Adamis Pharmaceuticals' stock split?

Adamis Pharmaceuticals shares reverse split on Monday, May 22nd 2023. The 1-70 reverse split was announced on Monday, May 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of Adamis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN) , Amarin (AMRN) , Sorrento Therapeutics (SRNE) , Verastem (VSTM) , Dynavax Technologies (DVAX) , Novavax (NVAX) , SCYNEXIS (SCYX) , Synergy Pharmaceuticals (SGYP) , Agile Therapeutics (AGRX) and OPKO Health (OPK) .

NASDAQ:ADMP

Adamis Pharmaceuticals (ADMP) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free ADMP Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: N/A
50-Day Range: $0.77
▼
$3.99
52-Week Range: N/A

Volume: 119,800 shs
Average Volume: 811,695 shs
Market Capitalization: $7.26 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Adamis Pharmaceuticals alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Adamis Pharmaceuticals Stock (NASDAQ:ADMP)

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease. Its products include SYMJEPI epinephrine injection for the emergency treatment of allergic reactions to stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances, and other allergens, as well as idiopathic or exercise-induced anaphylaxis; and ZIMHI naloxone injection for the treatment of opioid overdose. The company is headquartered in San Diego, California.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

Click for my No. 1 investment, all free of charge, click here.

ADMP Stock News Headlines

November 8, 2023 | morningstar.com

DMK Pharmaceuticals Corp DMK

September 7, 2023 | msn.com

Adamis changes name to DMK Pharmaceuticals, ticker to DMK

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

September 7, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus

August 21, 2023 | finanznachrichten.de

Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 21, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 4, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Announces Closing of $8.0 Million Public Offering

August 2, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

August 1, 2023 | msn.com

Adamis Pharmaceuticals Stock Soars To More Than Double - What's Going On?

August 1, 2023 | msn.com

Adamis stock soars as high as 480% amid asset sale, drug study news

July 28, 2023 | marketwatch.com

Adamis Pharma to Fund Clinical Study with University of Leiden Opioid Expert

July 28, 2023 | finance.yahoo.com

Adamis Pharmaceuticals to Fund ZIMHI® Clinical Study with University of Leiden Opioid Expert

June 26, 2023 | benzinga.com

Adamis Pharmaceuticals Announces NIH Grant Funding For Treatment Of Alcohol Use Disorder, Size Not Disclosed

June 26, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use Disorder

June 22, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention

June 4, 2023 | fool.com

Adamis Pharmaceuticals (NASDAQ: ADMP)

May 31, 2023 | benzinga.com

Adamis Pharmaceuticals CEO Awarded $210K Worth of Stock Options

May 31, 2023 | benzinga.com

Board Member at Adamis Pharmaceuticals Acquires Company Stock Options Worth 25,720 Shares

May 26, 2023 | finanznachrichten.de

Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals

May 25, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals

May 21, 2023 | seekingalpha.com

Adamis Pharma slips 19% on plans for reverse stock slip

May 19, 2023 | finanznachrichten.de

Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Reverse Stock Split

May 19, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Announces Reverse Stock Split

May 16, 2023 | finance.yahoo.com

Q1 2023 Adamis Pharmaceuticals Corp Earnings Call

May 15, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 8, 2023 | finance.yahoo.com

Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update

See More Headlines

Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/31/2022
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: NASDAQ:ADMP
CUSIP: N/A
CIK: 887247
Web: www.adamispharmaceuticals.com
Phone: (858) 997-2400
Fax: N/A
Employees: 11
Year Founded: 2006

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-26,480,000.00
Net Margins: -502.73%
Pretax Margin: -471.80%
Return on Equity: -420.53%
Return on Assets: -256.87%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.23
Quick Ratio: 0.19

Sales & Book Value

Annual Sales: $4.76 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($1.26) per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 9,360,000
Free Float: 9,237,000
Market Cap: $7.26 million
Optionable: Optionable
Beta: 1.27

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. David J. Marguglio (Age 53)
Co-Founder, Interim CFO. Pres & COO
Comp: $526.35k
Dr. Ebrahim Versi M.D. (Age 70)
Ph.D., CEO & Chair of the Board
Ms. Jennifer C. Suski
Sr. Director of Marketing
Mr. Eddie Wabern Glover (Age 73)
Chief Exec. Officer of US Compounding Inc
Mr. Robert B. Rothermel (Age 79)
Consultant

Key Competitors

View All Competitors

ADMP Stock Analysis - Frequently Asked Questions

How were Adamis Pharmaceuticals' earnings last quarter?: Adamis Pharmaceuticals Co. (NASDAQ:ADMP) released its earnings results on Thursday, March, 31st. The specialty pharmaceutical company reported ($4.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.80) by $1.40. Adamis Pharmaceuticals had a negative net margin of 502.73% and a negative trailing twelve-month return on equity of 420.53%. During the same quarter in the previous year, the business earned ($11.20) EPS.
When did Adamis Pharmaceuticals' stock split?: Adamis Pharmaceuticals shares reverse split on Monday, May 22nd 2023. The 1-70 reverse split was announced on Monday, May 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.
What other stocks do shareholders of Adamis Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK).

This page (NASDAQ:ADMP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Adamis Pharmaceuticals (ADMP) Stock Price, News & Analysis

About Adamis Pharmaceuticals Stock (NASDAQ:ADMP)

ADMP Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

ADMP Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info